| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |